IL6 and colitis: Furthermore, PELNs demonstrated the ability to suppress the expression of pro-inflammatory cytokines (IL-6, IL-12, IL-1β, and TNF-α) and MPO, and increase the levels of the anti-inflammatory cytokine IL-10, thereby alleviating DSS-induced colitis in mice.